NCT00267007 2014-06-04A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral NeuropathyJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2 Terminated32 enrolled 9 charts